Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience

Haematologica. 2023 Apr 1;108(4):1186-1189. doi: 10.3324/haematol.2022.282014.

¹ Faculty of Medicine, University of Toronto. asule095@uottawa.ca.
² Faculty of Medicine, University of Toronto.
³ Faculty of Medicine, University of Toronto; Division of Medical Oncology and Hematology, St. Michael's Hospital.
⁴ AbbVie, Inc., North Chicago, IL.
⁵ Faculty of Medicine, University of Toronto; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre.
⁶ Faculty of Medicine, University of Toronto; Sunnybrook Health Sciences Centre, Odette Cancer Centre.

No abstract available

Publication types